SUNESIS PHARMACEUTICALS INC - COM NEW (SNSS)

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM NEW
Total 13F shares
42,912,071
Share change
-2,224,443
Total reported value
$23,523,000
Put/Call ratio
54%
Price per share
$0.55
Number of holders
49
Value change
-$1,210,997
Number of buys
12
Number of sells
17

Institutional Holders of SUNESIS PHARMACEUTICALS INC - COM NEW (SNSS) as of Q2 2016

As of 30 Jun 2016, SUNESIS PHARMACEUTICALS INC - COM NEW (SNSS) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,912,071 shares. The largest 10 holders included GREAT POINT PARTNERS LLC, NEA Management Company, LLC, Palo Alto Investors, LLC, BVF INC/IL, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, DRIEHAUS CAPITAL MANAGEMENT LLC, First Eagle Investment Management, LLC, FMR LLC, and Frontier Wealth Management LLC. This page lists 49 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.